Exact Mass: 654.4624

Exact Mass Matches: 654.4624

Found 99 metabolites which its exact mass value is equals to given mass value 654.4624, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

FAHFA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14-O-22:6(4Z,7Z,10Z,13Z,16Z,19Z))

(4Z,7Z,10Z,12E,16Z,19Z)-14-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]docosa-4,7,10,12,16,19-hexaenoic acid

C44H62O4 (654.4648)


Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14-O-22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, is formed from the condensation of the carboxy group of docosahexaenoic acid (DHA) with the hydroxy group of 14-hydroxydocosahexaenoic acid. It is alternatively named 14-DHAHDHA since it is the 14-hydroxy isomer of the DHAHDLA (docosahexaenoic acid-hydroxydocosahexaenoic acid) family.

   

DG(14:0/6 keto-PGF1alpha/0:0)

(2S)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-3-hydroxypropyl tetradecanoic acid

C37H66O9 (654.4707)


DG(14:0/6 keto-PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/6 keto-PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(6 keto-PGF1alpha/14:0/0:0)

(2S)-1-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-3-hydroxypropan-2-yl tetradecanoic acid

C37H66O9 (654.4707)


DG(6 keto-PGF1alpha/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(6 keto-PGF1alpha/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(14:0/0:0/6 keto-PGF1alpha)

(2R)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-2-hydroxypropyl tetradecanoic acid

C37H66O9 (654.4707)


DG(14:0/0:0/6 keto-PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(6 keto-PGF1alpha/0:0/14:0)

(2S)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-2-hydroxypropyl tetradecanoic acid

C37H66O9 (654.4707)


DG(6 keto-PGF1alpha/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(14:0/TXB2/0:0)

(2S)-2-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-3-hydroxypropyl tetradecanoic acid

C37H66O9 (654.4707)


DG(14:0/TXB2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/TXB2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(TXB2/14:0/0:0)

(2S)-1-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-3-hydroxypropan-2-yl tetradecanoic acid

C37H66O9 (654.4707)


DG(TXB2/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(TXB2/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(14:0/0:0/TXB2)

(2R)-3-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-2-hydroxypropyl tetradecanoic acid

C37H66O9 (654.4707)


DG(14:0/0:0/TXB2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(TXB2/0:0/14:0)

(2S)-3-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-2-hydroxypropyl tetradecanoic acid

C37H66O9 (654.4707)


DG(TXB2/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/6 keto-PGF1alpha/0:0)

(2S)-2-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-3-hydroxypropyl 12-methyltridecanoic acid

C37H66O9 (654.4707)


DG(i-14:0/6 keto-PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/6 keto-PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(6 keto-PGF1alpha/i-14:0/0:0)

(2S)-1-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-3-hydroxypropan-2-yl 12-methyltridecanoic acid

C37H66O9 (654.4707)


DG(6 keto-PGF1alpha/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(6 keto-PGF1alpha/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/0:0/6 keto-PGF1alpha)

(2R)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-2-hydroxypropyl 12-methyltridecanoic acid

C37H66O9 (654.4707)


DG(i-14:0/0:0/6 keto-PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(6 keto-PGF1alpha/0:0/i-14:0)

(2S)-3-({7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]-6-oxoheptanoyl}oxy)-2-hydroxypropyl 12-methyltridecanoic acid

C37H66O9 (654.4707)


DG(6 keto-PGF1alpha/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/TXB2/0:0)

(2S)-2-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-3-hydroxypropyl 12-methyltridecanoic acid

C37H66O9 (654.4707)


DG(i-14:0/TXB2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/TXB2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(TXB2/i-14:0/0:0)

(2S)-1-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-3-hydroxypropan-2-yl 12-methyltridecanoic acid

C37H66O9 (654.4707)


DG(TXB2/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(TXB2/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-14:0/0:0/TXB2)

(2R)-3-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-2-hydroxypropyl 12-methyltridecanoic acid

C37H66O9 (654.4707)


DG(i-14:0/0:0/TXB2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(TXB2/0:0/i-14:0)

(2S)-3-{[(5Z)-7-[(2R,3S,4S)-4,6-dihydroxy-2-[(3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]hept-5-enoyl]oxy}-2-hydroxypropyl 12-methyltridecanoic acid

C37H66O9 (654.4707)


DG(TXB2/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Salzmanolin

Salzmanolin

C37H66O9 (654.4707)


   

3-(9-{(2R*,5S*)-5-[(1S*,4S*)-1,4-dihydroxy-4-{(2S*,5R*)-5-[(1S*)-1-hydroxyundecyl]tetrahydrofuran-2-yl}butyl]tetrahydrofuran-2-yl}-2,3-dihydroxynonyl)-5-methylfuran-2(5H)-one|rolifolin

3-(9-{(2R*,5S*)-5-[(1S*,4S*)-1,4-dihydroxy-4-{(2S*,5R*)-5-[(1S*)-1-hydroxyundecyl]tetrahydrofuran-2-yl}butyl]tetrahydrofuran-2-yl}-2,3-dihydroxynonyl)-5-methylfuran-2(5H)-one|rolifolin

C37H66O9 (654.4707)


   

Di-Ac-Podototarin

Di-Ac-Podototarin

C44H62O4 (654.4648)


   

irciniasulfonic acid O-methyl (5Z,9Z)-5,9-tetracosenoate

irciniasulfonic acid O-methyl (5Z,9Z)-5,9-tetracosenoate

C37H66O7S (654.4529)


   

PA(O-16:0/18:4(6Z,9Z,12Z,15Z))

1-hexadecyl-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphate

C37H67O7P (654.4624)


   

PA(P-16:0/18:3(6Z,9Z,12Z))

1-(1Z-hexadecenyl)-2-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate

C37H67O7P (654.4624)


   

PA(P-16:0/18:3(9Z,12Z,15Z))

1-(1Z-hexadecenyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate

C37H67O7P (654.4624)


   

2-(9R-(5Z,9Z-tetracosadienoyloxy)-3-methyl-2Z-decenoyloxy)-ethanesulfonic acid

2-(9R-(5Z,9Z-tetracosadienoyloxy)-3-methyl-2Z-decenoyloxy)-ethanesulfonic acid

C37H66O7S (654.4529)


   

FAHFA 44:12;O

(4Z,7Z,10Z,12E,16Z,19Z)-14-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyloxy)docosahexaenoic acid

C44H62O4 (654.4648)


   

PA O-34:4

1-(1Z-hexadecenyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate

C37H67O7P (654.4624)


   

annosquatin B

annosquatin B

C37H66O9 (654.4707)


   

DG(14:0/6 keto-PGF1alpha/0:0)

DG(14:0/6 keto-PGF1alpha/0:0)

C37H66O9 (654.4707)


   

DG(6 keto-PGF1alpha/14:0/0:0)

DG(6 keto-PGF1alpha/14:0/0:0)

C37H66O9 (654.4707)


   

DG(14:0/0:0/6 keto-PGF1alpha)

DG(14:0/0:0/6 keto-PGF1alpha)

C37H66O9 (654.4707)


   

DG(6 keto-PGF1alpha/0:0/14:0)

DG(6 keto-PGF1alpha/0:0/14:0)

C37H66O9 (654.4707)


   

DG(14:0/TXB2/0:0)

DG(14:0/TXB2/0:0)

C37H66O9 (654.4707)


   

DG(TXB2/14:0/0:0)

DG(TXB2/14:0/0:0)

C37H66O9 (654.4707)


   

DG(14:0/0:0/TXB2)

DG(14:0/0:0/TXB2)

C37H66O9 (654.4707)


   

DG(TXB2/0:0/14:0)

DG(TXB2/0:0/14:0)

C37H66O9 (654.4707)


   

DG(i-14:0/TXB2/0:0)

DG(i-14:0/TXB2/0:0)

C37H66O9 (654.4707)


   

DG(TXB2/i-14:0/0:0)

DG(TXB2/i-14:0/0:0)

C37H66O9 (654.4707)


   

DG(i-14:0/0:0/TXB2)

DG(i-14:0/0:0/TXB2)

C37H66O9 (654.4707)


   

DG(TXB2/0:0/i-14:0)

DG(TXB2/0:0/i-14:0)

C37H66O9 (654.4707)


   

DG(i-14:0/6 keto-PGF1alpha/0:0)

DG(i-14:0/6 keto-PGF1alpha/0:0)

C37H66O9 (654.4707)


   

DG(6 keto-PGF1alpha/i-14:0/0:0)

DG(6 keto-PGF1alpha/i-14:0/0:0)

C37H66O9 (654.4707)


   

DG(i-14:0/0:0/6 keto-PGF1alpha)

DG(i-14:0/0:0/6 keto-PGF1alpha)

C37H66O9 (654.4707)


   

DG(6 keto-PGF1alpha/0:0/i-14:0)

DG(6 keto-PGF1alpha/0:0/i-14:0)

C37H66O9 (654.4707)


   

Mgdg O-26:3_2:0

Mgdg O-26:3_2:0

C37H66O9 (654.4707)


   

Mgdg O-24:3_4:0

Mgdg O-24:3_4:0

C37H66O9 (654.4707)


   

Mgdg O-22:3_6:0

Mgdg O-22:3_6:0

C37H66O9 (654.4707)


   

Mgdg O-20:3_8:0

Mgdg O-20:3_8:0

C37H66O9 (654.4707)


   

Mgdg O-8:0_20:3

Mgdg O-8:0_20:3

C37H66O9 (654.4707)


   

Mgdg O-16:3_12:0

Mgdg O-16:3_12:0

C37H66O9 (654.4707)


   

Mgdg O-18:3_10:0

Mgdg O-18:3_10:0

C37H66O9 (654.4707)


   

Mgdg O-12:0_16:3

Mgdg O-12:0_16:3

C37H66O9 (654.4707)


   

Mgdg O-10:0_18:3

Mgdg O-10:0_18:3

C37H66O9 (654.4707)


   

MGDG(28:3)

MGDG(10:1(1)_18:2)

C37H66O9 (654.4707)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

FAHFA 18:5/O-26:7

FAHFA 18:5/O-26:7

C44H62O4 (654.4648)


   

FAHFA 18:6/O-26:6

FAHFA 18:6/O-26:6

C44H62O4 (654.4648)


   

FAHFA 19:5/O-25:7

FAHFA 19:5/O-25:7

C44H62O4 (654.4648)


   

FAHFA 19:6/O-25:6

FAHFA 19:6/O-25:6

C44H62O4 (654.4648)


   

FAHFA 20:5/O-24:7

FAHFA 20:5/O-24:7

C44H62O4 (654.4648)


   

FAHFA 20:6/O-24:6

FAHFA 20:6/O-24:6

C44H62O4 (654.4648)


   

FAHFA 21:5/O-23:7

FAHFA 21:5/O-23:7

C44H62O4 (654.4648)


   

FAHFA 21:6/O-23:6

FAHFA 21:6/O-23:6

C44H62O4 (654.4648)


   

FAHFA 21:7/O-23:5

FAHFA 21:7/O-23:5

C44H62O4 (654.4648)


   

FAHFA 22:5/O-22:7

FAHFA 22:5/O-22:7

C44H62O4 (654.4648)


   

FAHFA 22:6/O-22:6

FAHFA 22:6/O-22:6

C44H62O4 (654.4648)


   

FAHFA 22:7/O-22:5

FAHFA 22:7/O-22:5

C44H62O4 (654.4648)


   

FAHFA 23:5/O-21:7

FAHFA 23:5/O-21:7

C44H62O4 (654.4648)


   

FAHFA 23:6/O-21:6

FAHFA 23:6/O-21:6

C44H62O4 (654.4648)


   

FAHFA 23:7/O-21:5

FAHFA 23:7/O-21:5

C44H62O4 (654.4648)


   

FAHFA 24:6/O-20:6

FAHFA 24:6/O-20:6

C44H62O4 (654.4648)


   

FAHFA 24:7/O-20:5

FAHFA 24:7/O-20:5

C44H62O4 (654.4648)


   

FAHFA 25:6/O-19:6

FAHFA 25:6/O-19:6

C44H62O4 (654.4648)


   

FAHFA 25:7/O-19:5

FAHFA 25:7/O-19:5

C44H62O4 (654.4648)


   

FAHFA 26:6/O-18:6

FAHFA 26:6/O-18:6

C44H62O4 (654.4648)


   

FAHFA 26:7/O-18:5

FAHFA 26:7/O-18:5

C44H62O4 (654.4648)


   

MGDG O-28:3

MGDG O-28:3

C37H66O9 (654.4707)


   
   

PA O-14:0/20:4

PA O-14:0/20:4

C37H67O7P (654.4624)


   

PA O-14:1/20:3

PA O-14:1/20:3

C37H67O7P (654.4624)


   

PA O-16:0/18:4

PA O-16:0/18:4

C37H67O7P (654.4624)


   

PA O-16:1/18:3

PA O-16:1/18:3

C37H67O7P (654.4624)


   

PA O-16:2/18:2

PA O-16:2/18:2

C37H67O7P (654.4624)


   

PA P-14:0/20:3

PA P-14:0/20:3

C37H67O7P (654.4624)


   

PA P-14:0/20:3 or PA O-14:1/20:3

PA P-14:0/20:3 or PA O-14:1/20:3

C37H67O7P (654.4624)


   

PA P-16:0/18:3

PA P-16:0/18:3

C37H67O7P (654.4624)


   

PA P-16:0/18:3 or PA O-16:1/18:3

PA P-16:0/18:3 or PA O-16:1/18:3

C37H67O7P (654.4624)


   

PA P-16:1/18:2

PA P-16:1/18:2

C37H67O7P (654.4624)


   

PA P-16:1/18:2 or PA O-16:2/18:2

PA P-16:1/18:2 or PA O-16:2/18:2

C37H67O7P (654.4624)


   
   

PA P-34:3 or PA O-34:4

PA P-34:3 or PA O-34:4

C37H67O7P (654.4624)


   
   
   

3-[(13s)-13-hydroxy-13-[(5s,5's)-4-hydroxy-5'-[(1r,5s,6s)-1,5,6-trihydroxyundecyl]-[2,2'-bioxolan]-5-yl]tridecyl]-5-methyl-5h-furan-2-one

3-[(13s)-13-hydroxy-13-[(5s,5's)-4-hydroxy-5'-[(1r,5s,6s)-1,5,6-trihydroxyundecyl]-[2,2'-bioxolan]-5-yl]tridecyl]-5-methyl-5h-furan-2-one

C37H66O9 (654.4707)


   

8,13-dihydroxy-1-(5-hydroxy-5-methyl-2-oxofuran-3-yl)-13-[5-(1-hydroxytridecyl)oxolan-2-yl]tridecan-2-yl acetate

8,13-dihydroxy-1-(5-hydroxy-5-methyl-2-oxofuran-3-yl)-13-[5-(1-hydroxytridecyl)oxolan-2-yl]tridecan-2-yl acetate

C37H66O9 (654.4707)


   

(5r)-3-[(2r,3s)-9-[(2r,5s)-5-[(1s,4s)-1,4-dihydroxy-4-[(2s,5r)-5-[(1s)-1-hydroxyundecyl]oxolan-2-yl]butyl]oxolan-2-yl]-2,3-dihydroxynonyl]-5-methyl-5h-furan-2-one

(5r)-3-[(2r,3s)-9-[(2r,5s)-5-[(1s,4s)-1,4-dihydroxy-4-[(2s,5r)-5-[(1s)-1-hydroxyundecyl]oxolan-2-yl]butyl]oxolan-2-yl]-2,3-dihydroxynonyl]-5-methyl-5h-furan-2-one

C37H66O9 (654.4707)


   

3-[9-(5-{1,4-dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl}oxolan-2-yl)-2,3-dihydroxynonyl]-5-methyl-5h-furan-2-one

3-[9-(5-{1,4-dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl}oxolan-2-yl)-2,3-dihydroxynonyl]-5-methyl-5h-furan-2-one

C37H66O9 (654.4707)


   

(5r)-3-[(13r)-13-hydroxy-13-[(2s,2'r,4r,5s,5's)-4-hydroxy-5'-[(1r,5r,6s)-1,5,6-trihydroxyundecyl]-[2,2'-bioxolan]-5-yl]tridecyl]-5-methyl-5h-furan-2-one

(5r)-3-[(13r)-13-hydroxy-13-[(2s,2'r,4r,5s,5's)-4-hydroxy-5'-[(1r,5r,6s)-1,5,6-trihydroxyundecyl]-[2,2'-bioxolan]-5-yl]tridecyl]-5-methyl-5h-furan-2-one

C37H66O9 (654.4707)


   

(2r,8r,13r)-8,13-dihydroxy-1-[(5s)-5-hydroxy-5-methyl-2-oxofuran-3-yl]-13-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]tridecan-2-yl acetate

(2r,8r,13r)-8,13-dihydroxy-1-[(5s)-5-hydroxy-5-methyl-2-oxofuran-3-yl]-13-[(2r,5r)-5-[(1r)-1-hydroxytridecyl]oxolan-2-yl]tridecan-2-yl acetate

C37H66O9 (654.4707)